{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:29:10Z","timestamp":1793158150135,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":101,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81601108"],"award-info":[{"award-number":["81601108"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2021MH135 and ZR2016HQ14"],"award-info":[{"award-number":["ZR2021MH135 and ZR2016HQ14"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-10415-5","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T14:34:23Z","timestamp":1780756463000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["AS-IV attenuates nigral NLRP3 inflammasome in a Parkinson\u2019s disease mouse model via gut microbiota"],"prefix":"10.1038","volume":"9","author":[{"given":"Jinfeng","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruli","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongcai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"key":"10415_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2024.112366","volume":"187","author":"J Huang","year":"2024","unstructured":"Huang, J. et al. Pathological \u03b1-synuclein detected by real-time quaking-induced conversion in synucleinopathies. Exp. Gerontol. 187, 112366 (2024).","journal-title":"Exp. Gerontol."},{"key":"10415_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02410-4","volume":"19","author":"AF Pike","year":"2022","unstructured":"Pike, A. F. et al. Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson\u2019s disease. J. Neuroinflammation 19, 50 (2022).","journal-title":"J. Neuroinflammation"},{"key":"10415_CR3","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adh0604","volume":"15","author":"EA Albornoz","year":"2023","unstructured":"Albornoz, E. A. et al. Response to comment on \u201cinflammasome inhibition prevents \u03b1-synuclein pathology and dopaminergic neurodegeneration in mice. Sci. Transl. Med. 15, eadh0604 (2023).","journal-title":"Sci. Transl. Med."},{"key":"10415_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02830-w","volume":"20","author":"J Amo-Aparicio","year":"2023","unstructured":"Amo-Aparicio, J., Daly, J., H\u00f8jen, J. F. & Dinarello, C. A. Pharmacologic inhibition of NLRP3 reduces the levels of \u03b1-synuclein and protects dopaminergic neurons in a model of Parkinson\u2019s disease. J. Neuroinflammation 20, 147 (2023).","journal-title":"J. Neuroinflammation"},{"key":"10415_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","volume":"32","author":"MM Unger","year":"2016","unstructured":"Unger, M. M. et al. Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls. Park. Relat. Disord. 32, 66\u201372 (2016).","journal-title":"Park. Relat. Disord."},{"key":"10415_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101812","volume":"84","author":"JC Claudino Dos Santos","year":"2023","unstructured":"Claudino Dos Santos, J. C., Lima, M. P. P., Brito, G. A. C. & Viana, G. S. B. Role of enteric glia and microbiota-gut-brain axis in Parkinson disease pathogenesis. Ageing Res. Rev. 84, 101812 (2023).","journal-title":"Ageing Res. Rev."},{"key":"10415_CR7","doi-asserted-by":"publisher","first-page":"e848","DOI":"10.1212\/WNL.0000000000013225","volume":"98","author":"SJ Chen","year":"2022","unstructured":"Chen, S. J. et al. Association of fecal and plasma levels of short-chain fatty acids with gut microbiota and clinical severity in patients with Parkinson disease. Neurology 98, e848\u2013e858 (2022).","journal-title":"Neurology"},{"key":"10415_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2021.111376","volume":"150","author":"Y Hou","year":"2021","unstructured":"Hou, Y. et al. Neuroprotective effects of short-chain fatty acids in MPTP induced mice model of Parkinson\u2019s disease. Exp. Gerontol. 150, 111376 (2021).","journal-title":"Exp. Gerontol."},{"key":"10415_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-023-00798-6","volume":"18","author":"S Weng","year":"2023","unstructured":"Weng, S. et al. Astragaloside IV ameliorates experimental autoimmune myasthenia gravis by regulating CD4+ T cells and altering gut microbiota. Chin. Med. 18, 97 (2023).","journal-title":"Chin. Med."},{"key":"10415_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.05.036","volume":"75","author":"C Yang","year":"2019","unstructured":"Yang, C. et al. Astragaloside IV ameliorates motor deficits and dopaminergic neuron degeneration via inhibiting neuroinflammation and oxidative stress in a Parkinson\u2019s disease mouse model. Int. Immunopharmacol. 75, 105651 (2019).","journal-title":"Int. Immunopharmacol."},{"key":"10415_CR11","doi-asserted-by":"publisher","first-page":"115382","DOI":"10.1016\/j.expneurol.2025.115382","volume":"393","author":"YL Liu","year":"2025","unstructured":"Liu, Y. L. et al. Stereotactic infusion of rotenone into the SN induced a late-stage model of Parkinson\u2019s disease. Exp. Neurol. 393, 115382 (2025).","journal-title":"Exp. Neurol."},{"key":"10415_CR12","doi-asserted-by":"publisher","first-page":"1467132","DOI":"10.3389\/fphar.2024.1467132","volume":"15","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. Astragaloside IV alleviates inflammation and improves myocardial metabolism in heart failure mice with preserved ejection fraction. Front. Pharmacol. 15, 1467132 (2024).","journal-title":"Front. Pharmacol."},{"key":"10415_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-020-00988-6","volume":"9","author":"YF Hou","year":"2021","unstructured":"Hou, Y. F. et al. Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson\u2019s disease. Microbiome 9, 34 (2021).","journal-title":"Microbiome"},{"key":"10415_CR14","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/s41591-019-0504-5","volume":"25","author":"C B\u00e1rcena","year":"2019","unstructured":"B\u00e1rcena, C. et al. Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice. Nat. Med. 25, 1234\u20131242 (2019).","journal-title":"Nat. Med."},{"key":"10415_CR15","doi-asserted-by":"publisher","first-page":"108238","DOI":"10.1016\/j.celrep.2020.108238","volume":"33","author":"S Leclercq","year":"2020","unstructured":"Leclercq, S. et al. Gut microbiota-induced changes in \u03b2-hydroxybutyrate metabolism are linked to altered sociability and depression in alcohol use disorder. Cell Rep. 33, 108238 (2020).","journal-title":"Cell Rep."},{"key":"10415_CR16","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3390\/nu15040930","volume":"15","author":"TT Guo","year":"2023","unstructured":"Guo, T. T. et al. Neuroprotective effects of sodium butyrate by restoring gut microbiota and inhibiting TLR4 signaling in mice with MPTP-induced Parkinson\u2019s disease. Nutrients 15, 930 (2023).","journal-title":"Nutrients"},{"key":"10415_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-021-01107-9","volume":"9","author":"Z Zhao","year":"2021","unstructured":"Zhao, Z. et al. Fecal microbiota transplantation protects rotenone-induced Parkinson\u2019s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Microbiome 9, 226 (2021).","journal-title":"Microbiome"},{"key":"10415_CR18","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s12035-023-03566-7","volume":"61","author":"MD Wang","year":"2024","unstructured":"Wang, M. D. et al. Astragaloside IV inhibits rotenone-induced \u03b1-syn presentation and the CD4 T-cell immune response. Mol. Neurobiol. 61, 252\u2013265 (2024).","journal-title":"Mol. Neurobiol."},{"key":"10415_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/CM9.0000000000003318","volume":"138","author":"L Wang","year":"2025","unstructured":"Wang, L. et al. Gut microbiota and Parkinson\u2019s disease. Chin. Med. J. 138, 289\u2013297 (2025).","journal-title":"Chin. Med. J."},{"key":"10415_CR20","doi-asserted-by":"publisher","first-page":"104478","DOI":"10.1016\/j.yexmp.2020.104478","volume":"115","author":"B Ge","year":"2020","unstructured":"Ge, B., Li, S. L. & Li, F. R. Astragaloside-IV regulates endoplasmic reticulum stress-mediated neuronal apoptosis in a murine model of Parkinson\u2019s disease via the lincRNA-p21\/CHOP pathway. Exp. Mol. Pathol. 115, 104478 (2020).","journal-title":"Exp. Mol. Pathol."},{"key":"10415_CR21","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson, T. R. et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell 167, 1469\u20131480.e12 (2016).","journal-title":"Cell"},{"key":"10415_CR22","doi-asserted-by":"publisher","first-page":"9349","DOI":"10.1111\/jcmm.15586","volume":"24","author":"Q He","year":"2020","unstructured":"He, Q. et al. Astragaloside IV alleviates mouse slow transit constipation by modulating gut microbiota profile and promoting butyric acid generation. J. Cell. Mol. Med. 24, 9349\u20139361 (2020).","journal-title":"J. Cell. Mol. Med."},{"key":"10415_CR23","doi-asserted-by":"publisher","first-page":"8726","DOI":"10.3390\/ijms22168726","volume":"22","author":"P Sini","year":"2021","unstructured":"Sini, P. et al. Cyanobacteria, cyanotoxins, and neurodegenerative diseases: dangerous liaisons. Int. J. Mol. Sci. 22, 8726 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"10415_CR24","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10571-021-01066-7","volume":"42","author":"N Dogra","year":"2022","unstructured":"Dogra, N., Mani, R. J. & Katare, D. P. The gut-brain axis: two ways signaling in Parkinson\u2019s disease. Cell. Mol. Neurobiol. 42, 315\u2013332 (2022).","journal-title":"Cell. Mol. Neurobiol."},{"key":"10415_CR25","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3892\/mmr.2021.12374","volume":"24","author":"Q Lei","year":"2021","unstructured":"Lei, Q. et al. Roles of alpha\u2011synuclein in gastrointestinal microbiome dysbiosis\u2011related Parkinson\u2019s disease progression (review). Mol. Med. Rep. 24, 734 (2021).","journal-title":"Mol. Med. Rep."},{"key":"10415_CR26","doi-asserted-by":"publisher","first-page":"e0248482","DOI":"10.1371\/journal.pone.0248482","volume":"16","author":"TS Anthonymuthu","year":"2021","unstructured":"Anthonymuthu, T. S., Tao, F., Xing, X. & Jiang, R. L. Enteral nutrition modulation with n-3 PUFAs directs microbiome and lipid metabolism in mice. PLoS ONE 16, e0248482 (2021).","journal-title":"PLoS ONE"},{"key":"10415_CR27","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3389\/fneur.2020.01041","volume":"11","author":"A Cosma-Grigorov","year":"2020","unstructured":"Cosma-Grigorov, A. et al. Changes in gastrointestinal microbiome composition in PD: a pivotal role of covariates. Front. Neurol. 11, 1041 (2020).","journal-title":"Front. Neurol."},{"key":"10415_CR28","doi-asserted-by":"publisher","first-page":"652617","DOI":"10.3389\/fcimb.2021.652617","volume":"11","author":"KE Murros","year":"2021","unstructured":"Murros, K. E., Huynh, V. A., Takala, T. M. & Saris, P. E. J. Desulfovibrio bacteria are associated with Parkinson\u2019s disease. Front. Cell. Infect. Microbiol. 11, 652617 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10415_CR29","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.neuron.2019.06.013","volume":"103","author":"JW Mckinley","year":"2019","unstructured":"Mckinley, J. W. et al. Dopamine deficiency reduces striatal cholinergic interneuron function in models of Parkinson\u2019s disease. Neuron 103, 1056\u201372 (2019).","journal-title":"Neuron"},{"key":"10415_CR30","first-page":"864","volume":"21","author":"D Kumar","year":"2020","unstructured":"Kumar, D. et al. Medicinal perspective of indole derivatives: recent developments and structure-activity relationship studies. Curr. Drug Targets 21, 864\u2013891 (2020).","journal-title":"Curr. Drug Targets"},{"key":"10415_CR31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3892\/etm.2020.9557","volume":"21","author":"HL Wang","year":"2020","unstructured":"Wang, H. L., Zhang, J., Li, Y. P., Dong, L. & Chen, Y. Z. Potential use of Glutathione as a treatment for Parkinson\u2019s disease. Exp. Ther. Med. 21, 125 (2020).","journal-title":"Exp. Ther. Med."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10415-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10415-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10415-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:32:44Z","timestamp":1789425164000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10415-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10415"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-10415-5","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"31 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"1197"}}